Advanced Small Bowel Adenocarcinoma
2 clinical trials · Condition
◉ Watch Advanced Small Bowel Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Sacituzumab Tirumotecan (MK-2870) in Patients With Advanced Small Bowel Adenocarcinoma Refractory or Intolerant to Platinum-Based Combination Therapy (NCT07720258) | National Cancer Center, Japan | 2027-01-01 |
| Enfortumab Vedotin in Patients With Advanced Small Bowel Adenocarcinoma Refractory or Intolerant to Platinum-based Combination Therapy (NCT07347314) | National Cancer Center, Japan | 2025-11-04 |
Track Advanced Small Bowel Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.